Chronic enteroviral infection modifies broadly pancreatic cellular functions
Enteroviral infections are common viral infections with usually rather few symptoms and also believed to be linked to the onset […]
Researchers at the Johns Hopkins Kimmel Cancer Center discovered that a cell adhesion protein, E-cadherin, allows breast cancer cells to […] Levels of molecules associated with genetic function, such as microRNA, can be an important indicator of abnormal activity associated with […] Optimal methods for predicting treatment efficacy in patients with esophageal cancer are seriously lacking. But now, researchers from Japan have […] A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded […] Researchers at the George Washington University (GW) Cancer Center found that the enzyme USP15 could potentially lead to new treatments […] Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53. […] A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type […] Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond […] Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early […]Pancreatic Cancer
Breast cancer cells ‘stick together’ to spread through the body during metastasis
Methylation of microRNA may be a new powerful biomarker for cancer
Lymph nodes can predict survival in patients with esophageal cancer
Humanization of antibodies targeting human herpesvirus 6B
Enzyme USP15 may have potential role in future treatment of various cancers
Mutant protein tackles DNA guardian to promote cancer development: Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53
Diabetes may be an early manifestation of pancreatic cancer
Organoid profiling identifies treatments for pancreatic cancer: They could be used to select the treatments most likely to work in specific patients
Deadly cancers show early, detectable differences from benign tumors: Small study in colorectal tumors distinguishes those that are ‘born bad’